News Desk, AnyTV, New Delhi
Published by: Amit Mandal
Updated Sat, 05 Mar 2022 04:19 PM IST
Summary
DCGI on February 4 allowed emergency use for the Sputnik Lite vaccine in India subject to certain regulatory provisions.
hear the news
hear the news
DCGI had given permission under the conditions
DCGI on February 4 allowed emergency use for the Sputnik Lite vaccine in India subject to certain regulatory provisions. Hyderabad-based Dr. Reddy’s Laboratories had put forward its proposal to DCGI to conduct phase-3 trial of Sputnik Lite vaccine as a booster dose. Sputnik Light is similar to Component-1 of Sputnik V.
An official source said that the CDSCO’s Subject Expert Committee (SEC) on COVID-19, after detailed deliberations, reviewed the application on Friday and with the condition to start the trial with the Sputnik Lite vaccine, Phase-III. Recommended allowing clinical trials. For this the firm has already been granted emergency use in the country subject to certain regulatory provisions. The Sputnik Lite vaccine is approved in 29 countries, including Argentina and Russia.
Expansion
DCGI had given permission under the conditions
DCGI on February 4 allowed emergency use for the Sputnik Lite vaccine in India subject to certain regulatory provisions. Hyderabad-based Dr. Reddy’s Laboratories had put forward its proposal to DCGI to conduct phase-3 trial of Sputnik Lite vaccine as a booster dose. Sputnik Light is similar to Component-1 of Sputnik V.
An official source said that the CDSCO’s Subject Expert Committee (SEC) on COVID-19, after detailed deliberations, reviewed the application on Friday and with the condition to start the trial with the Sputnik Lite vaccine, Phase-III. Recommended allowing clinical trials. For this the firm has already been granted emergency use in the country subject to certain regulatory provisions. The Sputnik Lite vaccine is approved in 29 countries, including Argentina and Russia.